(Q53634274)

English

Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

0 references

0 references

ventricular dysfunction

1 reference

based on heuristic

inferred from title

left ventricular dysfunction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Martial Bourassa

5

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

author name string

Glick H

1

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

Cook J

2

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

Kinosian B

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

Pitt B

4

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

Pouleur H

6

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

Gerth W

7

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

publication date

1 December 1995

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

Journal of Cardiac Failure

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

1

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

5

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

371-380

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

Epidemiology of heart failure in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Physician utilization of laboratory procedures to monitor outpatients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. The SOLVD Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2805%2980006-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1071-9164(05)80006-5

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/12836712

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53634274&oldid=1835244198"